The state of CBD in dietary supplements
The actual business opportunity of cannabidiol (CBD) is still shrouded with mystery when it comes to regulatory considerations. A panel discussion of experts will analyse the business and regulatory trends affecting this hemp-based compound in the natural products industry.
On the panel: Robert Hoban, managing partner, Hoban Law Group; Colleen Keahey, executive director, Hemp Industries Association (HIA); Sean Murphy, founder and publisher, Hemp Business Journal; Jim Prochnow, shareholder, Greenberg Traurig.
Thursday, Sept. 28 @ 2 – 4 PM